The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Karthik Suresh(Johns Hopkins University), Franco R. D’Alessio(University of Maryland, Baltimore), Evan J. Lipson(Bloomberg (United States)), Julie R. Brahmer(Johns Hopkins University), David S. Ettinger(Johns Hopkins University), Lonny Yarmus(Johns Hopkins University), Aanika Balaji(Johns Hopkins University), Cheng Ting Lin(Johns Hopkins University), Laura C. Cappelli(Center for Rheumatology), Jennifer S. Mammen(Johns Hopkins Medicine), Jarushka Naidoo(Sidney Kimmel Comprehensive Cancer Center), Hans C. Lee(The University of Texas MD Anderson Cancer Center), Valsamo Anagnostou(Johns Hopkins University), Mājid Shafiq(Pulmonary and Critical Care Associates), Kristen A. Marrone(Johns Hopkins University), Mark J. Soloski(Center for Rheumatology), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), Ronan J. Kelly(Baylor University Medical Center), Christine L. Hann(Johns Hopkins University), Marcia Villegas de Flores(Center for Rheumatology), David Feller‐Kopman(Dartmouth–Hitchcock Medical Center), Sonye K. Danoff(Johns Hopkins University), Josephine Feliciano(Sidney Kimmel Comprehensive Cancer Center), Tsvi Palmer(Pulmonary and Critical Care Associates), Ye Xiong(Wenzhou Medical University), Qiong Zhong(Ganzhou People's Hospital), Andrew D. Lerner(Pulmonary and Critical Care Associates), Benjamin Levy(Johns Hopkins University)
Cited by 198
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k